Total planned funding: $426,605,631
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Namibia | $426,605,631 |
Organizational Types
NGO | $106,217,446 |
Private Contractor | $95,903,492 |
Own Agency | $70,435,517 |
Host Country Government Agency | $54,959,899 |
University | $40,608,543 |
Unknown | $36,711,012 |
Parastatal | $7,392,958 |
Other USG Agency | $4,760,027 |
Implementing Agency | $3,932,934 |
FBO | $3,810,045 |
Multi-lateral Agency | $1,873,758 |
Program Areas
Treatment | $122,452,075 |
Care | $85,695,800 |
Prevention | $84,817,835 |
Governance and Systems | $59,082,973 |
Management and Operations | $44,407,470 |
Testing | $30,149,478 |
Budget Codes
HTXS: Treatment: Adult Treatment | $99,647,405 |
HVMS: Management and Operations | $44,407,470 |
HKID: Care: Orphans and Vulnerable Children | $32,999,348 |
HBHC: Care: Adult Care and Support | $30,756,598 |
HVCT: Testing: HIV Testing and Counseling | $30,149,478 |
OHSS: Health Systems Strengthening | $28,029,210 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $26,240,219 |
HVSI: Strategic Information | $23,469,392 |
HVOP: Sexual Prevention: Other Sexual Prevention | $21,491,267 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $14,988,830 |
HVTB: Care: TB/HIV | $14,334,944 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $13,955,559 |
HTXD: Treatment: ARV Drugs | $12,408,923 |
PDTX: Treatment: Pediatric Treatment | $10,395,747 |
PDCS: Care: Pediatric Care and Support | $7,604,910 |
HLAB: Laboratory Infrastructure | $7,584,371 |
HMBL: Biomedical Prevention: Blood Safety | $4,533,898 |
HMIN: Biomedical Prevention: Injection Safety | $3,608,062 |
Top Partner Programs
Potentia Namibia:
$53,207,665
Countries/Regions
USG Aggregated Agencies:
$45,386,962
Countries/Regions
Not Available:
$29,531,925
Countries/Regions